Evommune, Inc. (EVMN)
NYSE · Healthcare
Evommune, Inc. annual/quarterly total liabilities history from 2024 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Evommune, Inc. total liabilities for the quarter ending December 31, 2025 were 19.4M, a 32.04% decrease year-over-year.
- Evommune, Inc. total liabilities for 2025 were 19.4M, a 32.04% decrease from 2024.
- Evommune, Inc. total liabilities for 2024 were 28.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Evommune, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $19 |
| 2024 | $29 |
| Evommune, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $19 |
| 2024-12-31 | $29 |
Evommune, Inc. Total Liabilities — FAQ
Evommune, Inc. (EVMN) total liabilities over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EVMN's total liabilities history?
The chart and table above show Evommune, Inc.'s total liabilities by year and by quarter, including the growth rate.